Forging the next frontier with QSP
The Certara Quantitative Systems Pharmacology (QSP) group is a global organization focused on the impactful application of QSP and mechanistic PKPD modeling and simulation in drug discovery and development.
We are leading several first-of-its-kind QSP Consortia with more than 10 global pharmaceutical companies and have a rapidly expanding consultancy portfolio. Our QSP scientists work in close collaboration with other Certara staff and clients to generate and use state-of-the-art mechanistic models for decision making in pharmaceutical R&D.
We are seeking highly motivated and talented QSP modelling experts at all levels, who share our passion for using quantitative approaches to understand and impact complex drug discovery and development questions. Positions are available at various levels of experience across our global locations and for flexible, home-based roles.
QSP Research Associate
Our QSP scientists work in close collaboration with other staff and clients to generate and use state-of-the-art mechanistic models for decision making in pharmaceutical R&D. The models are designed in close dialogue with clients and developed with a view to creating user-friendly tools that will inform drug development programs from discovery to regulatory filing. For this role, you should have postdoctoral experience in systems modelling for drug discovery/ development teams and PhD (or equivalent) in life sciences, engineering, computer sciences, mathematics, physics or equivalent. It is also essential that you have solid understanding of PKPD, pharmacology and biology and its application in drug discovery and development.
Quantitative Systems Pharmacology Positions (All Levels)
We are seeking highly motivated and talented QSP modelling experts at all levels, who share our passion for using quantitative approaches to understand and impact complex drug discovery and development questions. Besides our well-established leadership in applied QSP approaches in Immunology and Immuno-Oncology, we are now also the leading provider of QSP approaches in neuro-degenerative diseases through Certara’s recent acquisition of the In Silico Biosciences modelling platform.
製薬業界（SanofiおよびPfizer）において20 年以上の経験があります。QSPプロジェクトに重要な技術と経験をもたらし、サターラの戦略的な開発に貢献しています。また、CPT のEditor-in-Chiefでもあります。
計算生物学の分野に25年にわたって携わってきました。ゲノムスケールの代謝ネットワークモデルに基づいて、分子ネットワークにおけるダイナミクスや拘束の解析を目的としたモデルやソフトウェアを発表しています。現在、がん免疫と免疫原性の研究に積極的に取り組んでいます。英国のサリー大学においてシステム生物学の客員教授も務めています。
製薬業界（SanofiおよびPfizer）において20 年以上の経験があります。QSPプロジェクトに重要な技術と経験をもたらし、サターラの戦略的な開発に貢献しています。また、CPT のEditor-in-Chiefでもあります。
計算生物学の分野に25年にわたって携わってきました。ゲノムスケールの代謝ネットワークモデルに基づいて、分子ネットワークにおけるダイナミクスや拘束の解析を目的としたモデルやソフトウェアを発表しています。現在、がん免疫と免疫原性の研究に積極的に取り組んでいます。英国のサリー大学においてシステム生物学の客員教授も務めています。
